CJC1295 (No DAC) 10mg, Ipamorelin 5mg

Description

This research blend combines two of the most studied peptides in growth hormone secretagogue research — CJC1295 (No DAC) and Ipamorelin. Each compound targets different but complementary receptors in the growth hormone axis, making this pairing a popular subject in studies examining GH release, body composition, and metabolic regulation in animal models.

CJC1295 (without DAC) is a modified form of GHRH (Growth Hormone Releasing Hormone) that stimulates the pituitary to release growth hormone. Ipamorelin is a selective GHRP (Growth Hormone Releasing Peptide) that acts on the ghrelin receptor to trigger a clean, targeted pulse of GH release — notably without significantly stimulating cortisol or prolactin, which makes it a particularly useful research tool. Together, this combination is widely used in studies exploring growth hormone biology, muscle physiology, and metabolic function.

Supplied as a lyophilised powder. For research purposes only.